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tients have a titer of 1:160 at one week. However, in an
outbreak involving type A organisms, that titer would be
considered diagnostic of tularemia, because few serologic
surveys have been performed in areas where infection with
the type A strain is endemic and in persons who have no his-
tory of tularemia. Patients who have had type A pneumoni-
tis do have persistent agglutinating-antibody titers for sev-
eral years and should be immune to reinfection, if they are
immunocompetent.
Pérez-Castrillón et al. have reported the use of fluoro-
quinolones in the treatment of patients with tularemia. I was
aware of their report and should have acknowledged their
work. In their study, the less virulent form of F. tularensis
was the causative microbe. Presumably, disease caused by
type A organisms will be as responsive as the less virulent
form. However, only a few patients with type A disease have
been successfully treated.
RICHARD HORNICK, M.D.
Orlando Regional Healthcare
Orlando, FL 32806
dickh@orhs.org
1. Tularemia — Oklahoma, 2000. MMWR Morb Mortal Wkly Rep 2001;
50:704-6.
Case 38-2001: Paraneoplastic Encephalomyelitis 
and Sensory Ganglioneuropathy
To the Editor: In discussing the case of paraneoplastic
ganglionopathy with encephalopathy (Dec. 13 issue),1 Am-
ato and Anderson focused on the differential diagnosis and
the causes of sensory ganglionopathies. Because of the pri-
mary impairment of T-shaped sensory neurons, ganglion-
opathies are characterized by a specific pattern of joint,
muscle, and skin denervation involving myelinated and un-
myelinated axons in a fashion that is not length-dependent,
leading to distinct clinical, neurophysiological, and neuro-
pathological findings. Typically, skin biopsy demonstrates
similar decreases in fiber density at distal and proximal sites.2
Moreover, evidence of involvement of the central sensory
pathway can be used to localize the disease process to the
dorsal-root ganglia and differentiate ganglionopathies from
axonal neuropathies. Magnetic resonance imaging (MRI) of
the spinal cord can show high signal intensity on T2-weight-
ed images throughout the length of the posterior columns.3
In this case, the linear hyperintensity on the posterior aspect
of the cervical spine probably reflected the degeneration of
central sensory projections observed on neuropathological
examination and would have been better demonstrated by
axial MRI scanning at different levels.
The authors report a number of disorders associated with
sensory ganglionopathies, but additional disorders with such
associations include chronic autoimmune hepatitis,3 among
autoimmune diseases, and infection with Epstein–Barr vi-
rus,4 varicella–zoster virus,5 or measles virus, among infec-
tious diseases. Finally, sensory neurons of dorsal-root ganglia
are primarily affected in many genetic diseases, including he-
reditary sensory autonomic neuropathies, Fabry’s disease, vi-
tamin E deficiency, Friedreich’s ataxia, and other types of
spinocerebellar degeneration.3,6
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Dr. Amato replies:
To the Editor: Lauria and colleagues have performed el-
egant studies of epidermal nerve fiber density1 and spinal
MRI findings2 in patients with sensory ganglionopathies.
With regard to the case of paraneoplastic encephalomyelitis
and sensory ganglioneuropathy, they suggest that the linear
abnormality noted on the MRI scan of the cervical spine may
be secondary to degeneration of the posterior columns re-
lated to the sensory ganglionopathy. However, I chose not
to overinterpret this subtle abnormality, which was present
only on the sagittal image, because concurrent signal chang-
es were not noted on the axial images. Skin-biopsy specimens
were not readily available, and more important, would not
have provided any more information that would have been
useful for localization than was already available from the
clinical history and examination.
The time constraints of the clinicopathological conference
did not allow me to present a differential diagnosis of every
reported disease associated with damage to the sensory gan-
glia. Instead, I tried to review the pertinent aspects of the
patient’s history, neurologic examination, and workup that
would allow for a reasonable differential diagnosis and spec-
ification of further diagnostic testing required to make the
correct diagnosis. In a patient with known small-cell lung
cancer, an altered mental status, pseudoathetosis, myoclonus,
and sensory ataxia, there was no differential diagnosis. Nev-
ertheless, I tried to discuss common neuropathies that occur
in the setting of cancer. I would never consider chronic au-
toimmune hepatitis infection with Epstein–Barr virus, var-
icella–zoster virus, or measles virus or any of the inherited
neuropathies listed by Lauria and colleagues as possible caus-
es of this patient’s neurologic deterioration. The patient had
an obvious paraneoplastic disorder, which was eventually
confirmed by the demonstration of anti-Hu antibodies in the
serum and cerebrospinal fluid and by the autopsy findings.
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